生物製劑商品化－以庫斯蘇力菌為例

The Commercialization of Taiwan Indigenous Bacillus thuringiensis Subsp. kurstaki E911

曾經洲(Ching-Chou Tzeng)

《臺中區農業改良場特刊》 121號 (2014/03) Pp. 151-153

摘要

藥毒所成功產業化開發庫斯蘇力菌E-911（Bacillus thuringiensis subsp. kurstaki E911）生物農藥。依照生物農藥登記註冊之要求，運用生物學、微生物學及生物技術，篩選、鑑定新穎蘇力菌菌株，選擇此生物活性優秀菌株，製備完整的註冊登記資料及成熟的擴大量產技術和製劑配方技術，技轉產業界，協助業者逐步放大醱酵量產產程和製劑配方技術之規模，完成產程開發及建立品管技術，並協助產品完成生物農藥註冊登記，完成本土蘇力菌生物殺蟲劑之產業化歷程。

關鍵字

生物農藥 ； 產業化 ； 蘇力菌

並列摘要

Agriculture aims to enhance not only better quality, safety of agricultural products but also environment protection and leisure function of agriculture business. Bacillus thuringiensis (Bt) is considered to be one of the most potential biopesticides to replace some chemical pesticides. For example, the development of indigenous Btk E911, that can control Diamond-back moth, cabbage lopper, cabbage worm, and tussock moth, we have been according to the requirements of registration, use the microbial technology and biotechnology to select and identify new isolates. When we find one isolate has the best bioactivity, we not only try to pilot scale up, but also test the animal toxicity. Then, this champion isolate and the techniques, including basic mass production process, quality control process and field test results, transfer to cooperative company to become a commercial product.

並列關鍵字

Biopesticide ； Commercialization ； Bacillus thuringiensis